• $.$$


Naturally Splendid Secures Distributor for NATERA Plant Based Foods

November 30, 2020-05:00 AM EDT

Vancouver, British Columbia – The Newswire – November 30, 2020 - Naturally Splendid Enterprises Ltd. ("Naturally Splendid", "NSE" or "the Company") (FRANKFURT:50N) (TSXV:NSP) (OTC:NSPDF) is pleased to announce that the Company has listed three (3) NATERA Plant Based Food entrees with a leading Canadian distributor in their multiple British Columbia distribution centres.

READ FULL NEWS

Naturally Splendid Reports Third Quarter Results for 2020

November 27, 2020-05:50 AM EDT

Vancouver, British Columbia, November 27, 2020 - Naturally Splendid Enterprises Ltd. ("Naturally Splendid", “NSE” or “the Company”) (FRANKFURT:50N) (TSX-V:NSP) (OTC:NSPDF) announces its unaudited financial results for the nine months ended September 30, 2020.  All amounts are in Canadian dollars and are prepared in accordance with International Financial Reporting Standards.

READ FULL NEWS

Naturally Splendid Announces Advisory Board Addition

November 13, 2020-10:58 PM EDT

Vancouver, British Columbia – The Newswire – November 13, 2020 - Naturally Splendid Enterprises Ltd. ("Naturally Splendid", "NSE" or "the Company") (FRANKFURT:50N) (TSXV:NSP) (OTC:NSPDF) is pleased to announce the appointment of Mr. Kris Tarr to the Advisory Board, assisting in the area of e-commerce and online marketing.

READ FULL NEWS

Health Canada Provides Authorization Letter for Naturally Splendid JV, PLASM Pharmaceutical to Begin COVID-19 Phase 2 Clinical Trial

November 3, 2020-03:17 PM EDT

VANCOUVER, British Columbia, November 3, 2020 -- Naturally Splendid Enterprises Ltd. (“Naturally Splendid” or “NSE”) (TSX-V:NSP) (OTCQB:NSPDF) (Frankfurt:50N) is pleased to announce that further to the Company’s earlier announcements, Health Canada has now provided a Notice of Authorization to proceed with a phase 2 clinical trial for a potential COVID-19 treatment utilizing the target drug CavaltinibTM.

READ FULL NEWS
[stock-quotes-list]
?
This website collects data via Google Analytics. Click here to opt in. Click here to opt out.
×